cocaine and haloperidol decanoate

cocaine has been researched along with haloperidol decanoate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Richardson, NR; Roberts, DC; Smith, AM	1
Dhopesh, V; Gamble, G; Maany, I; Macfadden, A	1

Other Studies

2 other study(ies) available for cocaine and haloperidol decanoate

Article	Year
A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats. Drug and alcohol dependence, 1994, Volume: 36, Issue:1 Topics: Animals; Cocaine; Flupenthixol; Haloperidol; Injections, Intramuscular; Male; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Substance-Related Disorders; Tranquilizing Agents	1994
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine. Psychiatric services (Washington, D.C.), 1997, Volume: 48, Issue:1 Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia	1997

Article

Year

A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats.

Drug and alcohol dependence, 1994, Volume: 36, Issue:1

Topics: Animals; Cocaine; Flupenthixol; Haloperidol; Injections, Intramuscular; Male; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Substance-Related Disorders; Tranquilizing Agents

1994

Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.

Psychiatric services (Washington, D.C.), 1997, Volume: 48, Issue:1

Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia

1997